Abiopharma

ASCENDIS PHARMA A/S (ASND) Files Form 6-K

(10% Negative) NEKTAR THERAPEUTICS (NKTR) Announces Delay in period Trials for alopecia areata SAN FRANCISCO Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Safe Pro Reports on Share Repurchase Program, Reinforcing Commitment to Shareholder Value and Capital Return

Amneal Pharmaceuticals, Inc. - Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results withCREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching fromRYTARY®

(70% Positive) ASTEC INDUSTRIES INC (ASTE) Reports Q2 2026 Financial Results

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

(99% Neutral) VISIONWAVE HOLDINGS, INC. (VWAV) Announces New Board Appointment

COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations

POSaBIT to Host Fourth Quarter and FY 2025 Earnings Conference Call

(80% Positive) TOPBUILD CORP (BLD) Announces Business Combination

Fiserv to Release First Quarter Earnings Results on May 5, 2026 and Confirms Details for May 14, 2026 Investor Day

(99% Neutral) BAKKT, INC. (BKKT) Announces Business Combination

McKesson Corporation - McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions

RADIOPHARM THERANOSTICS LTD (RADX) Files Form 6-K

(99% Neutral) MICROSTRATEGY, INC. (MSTR) Announces Business Combination